Abstract: Disclosed is a processing device for a lithium battery positive electrode material, including a base, where the base is fixedly provided with barrel bodies by means of a support, a sleeve is rotatably clamped between the two barrel bodies, a stirring assembly transversely penetrates through interiors of the barrel bodies and the sleeve, the base is further provided with a power mechanism, and the power mechanism separately drives the sleeve and the stirring assembly to rotate. Due to the cooperation of the barrel bodies, the sleeve and the stirring assembly, the stirring assembly can effectively scrape attachments on the inner walls of the barrel bodies, and a first stirring blade in the sleeve and a second stirring blade in the stirring assembly are cooperated to stir, gather and further disperse and disarrange the material, such that the material can be mixed more uniformly.

Abstract: The present disclosure discloses a method for recycling a lithium-ion battery electrolyte. After the waste lithium-ion battery is discharged, it is frozen and disassembled to obtain a battery cell containing an electrolyte. The battery cell is immersed in a lithium hydroxide solution containing a catalyst for reaction. The battery cell after the reaction is taken out and washed. The washing solution is mixed with the lithium hydroxide solution after the reaction to obtain a mixed solution. The mixed solution is filtered to obtain a filtrate and a filter residue. The filter residue is reacted with a hydrofluoric acid solution to obtain anhydrous lithium salt. The anhydrous lithium salt is mixed with an organic solution, and PF5 gas is introduced. The mixture is reacted, and filtered to obtain an organic liquid. The organic solution is frozen and filtered to obtain lithium hexafluorophosphate.

Abstract: A method for recycling and treating an electrolytic solution of a lithium ion battery includes S1: cooling a fully discharged lithium ion battery below a freezing point of the electrolytic solution, and then disassembling and crushing the lithium ion battery to obtain a crushed solid containing the electrolytic solution, S2: under a protection of an inert gas, placing the crushed solid in a supercritical CO2 extraction instrument in which an entrainer is added; S3: conducting extraction; and S4: collection an extraction product with a cryogenic device, and adsorbing water in the extraction product using a 4 ? type lithiated molecular sieve, adsorbing HF in the extraction product using weak-base anion-exchange resin and adsorbing organic acid and alcohol in the extraction product using a 5 ? type lithiated molecular sieve.

Abstract: Disclosed is an apparatus for efficiently pretreating and recycling a waste battery, which includes a bottom plate, a recycling device, a conveying device and a treatment device, and one end of a top portion of the bottom plate is fixedly mounted with a bottom portion of the conveying device. According to the invention, by arranging a fixing assembly and the recycling device, a suction pump can suck a slurry and an electrolyte in a battery downwardly for dropping, and a driving assembly can rapidly convey the slurry and the electrolyte in the battery to the treatment device for treatment at the same time.

Abstract: Disclosed is a method for preparing a graphene-based sodium ion battery negative electrode material, including adding graphene oxide into ethanol absolute, carrying out ultrasonic treatment at a certain temperature to obtain a graphene oxide alcohol dispersion, then preparing a sodium hexanitritocobaltate solution, adding the graphene oxide alcohol dispersion into the sodium hexanitritocobaltate solution, carrying out solid-liquid separation to obtain a solid, isolating the solid from oxygen for calcination, and washing and drying to obtain a graphene-based sodium ion battery negative electrode material.

Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.

Abstract: A method for preparing 1,3-propanediol with a high space-time yield, in which A methyl 3-hydroxypropionate solution is pumped into a tubular fixed-bed reactor loaded with a surface modifier-coated nano-Cu-based catalyst for continuous hydrogenation to obtain a reaction mixture, where the catalyst includes Cu as active component, a metal oxide XOn/2 as additive and a SiO2—SnO2 composite carrier. The reaction mixture is subjected to rectification to separate light components from heavy components, where the light components include methanol, n-propanol, methyl propionate, methyl 3-hydroxypropionate and 1,3-propanediol, and the heavy components include 1,3-propanediol mono-propionate and 1,3-propanediol mono-3-hydroxypropionate. The heavy components are fed back to the tubular fixed-bed reactor for secondary hydrogenation, and the light components are separated to obtain 1,3-propanediol.

Abstract: The present disclosure relates to an application of Antarctic red pigment in a preparation of drugs for treatment and prevention of hyperuricemia, which belongs to the field of biomedicine. The present disclosure studies a fermentation product of existing fungi Geomycos sp. wnf-18C or Geomycos sp. wnf-15A, and finds that the Antarctic red pigment produced by the fermentation product has good therapeutic effects on hyperuricemia induced by high purines. Thus, this pigment has application value in the preparation of drugs for hyperuricemia induced by high purine.

Abstract: An information processing method is provided. The method is applied to a touch terminal capable of presenting a graphical user interface. The graphical user interface includes a virtual character and at least part of a game scene. The method includes: determining first orientation information of at least one target virtual object that satisfies a prompt trigger event in the game scene; determining a sub-identifier corresponding to the first orientation information in a first graphical identifier, wherein the first graphical identifier is set around the virtual character; and displaying the prompt trigger event graphically on the graphical user interface through the sub-identifier. A processing apparatus, an electronic device and a storage medium are also disclosed.

Abstract: The invention provides engineered mitochondria and a preparation method thereof, and relates to the technical field of mitochondria. The engineered mitochondria are formed by attaching exogenous cell membranes to outer membranes of exogenous mitochondria. The preparation method comprises the following steps: S1: extracting exogenous cell membranes from cells; S2: separating and extracting exogenous mitochondria from cells or tissue; and S3: mixing the separated and extracted exogenous mitochondria with the exogenous cell membranes in a specific ratio, thereby attaching the exogenous cell membranes to the outer membranes of the exogenous mitochondria to obtain the engineered mitochondria. The invention enables the production of engineered mitochondria with enhanced biological activity, exhibiting improved therapeutic effects on mitochondrial dysfunction-related disorders.

Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.

Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.

Abstract: A fully-automatic protein purification system device includes a chromatography unit, a first drive unit, a connecting pipeline, a locating unit, a second drive unit, a first container, a second container, a first valve, a second valve, and a control unit. The fully-automatic protein purification system device can fully automate the protein chromatography purification with a simple device structure and a low cost, has low requirements for the quality of a sample solution, will not cause blockage of a pipeline, has a wide application range, can greatly improve the automation of protein chromatography purification in the biology field, and can reduce the manual investment.

Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.

Abstract: A microfluidics-based nanoparticle synthesis system, a device and a synthesis method thereof are provided. The nanoparticle synthesis system comprises: a microfluidic chip; a reagent bottle which is connected with the microfluidic chip; and a flow control assembly comprising a pressure controller which is used for controlling the pressure in the reagent bottle. The system achieves high-accuracy flow control, and a microfluidic chip that can achieve high-efficiency and rapid mixing is also used in combination to finally achieve high-throughput and high-uniformity nanoparticle synthesis. A user may adjust the same instrument as required to achieve different throughputs without redesigning the instrument.

Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.

Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.

Abstract: The present invention pertains to pharmaceutical chemical field, and relates to a sterol derivative as well as preparation method and uses thereof. Specifically, the present invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, ester or ether thereof, wherein, R1 is selected from the group consisting of —OH, ?O(carbonyl), H, and C1-C3 alkyl; R2 is selected from the group consisting of —OH, H, and C1-C3 alkyl; R3 is selected from the group consisting of —OH, ?O, H, and C1-C3 alkyl; R4 is selected from the group consisting of —OH, H, and C1-C3 alkyl; and none, one, two, three or four of R1, R2, R3, and R4 are —OH. The compound of the present invention can inhibit HMG-CoA reductase, tumor cells and lipase effectively, and is a potential drug for reducing blood-fat, antitumors, or for losing weight.